We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Wide Surgical Margins Favored for Ductal Carcinoma in Situ

By HospiMedica International staff writers
Posted on 05 Apr 2012
Breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS) should aim for wide margins to keep recurrence risk low, even if the patient is receiving radiotherapy, according to a new meta-analysis study.

Researchers at the University of Minnesota School of Public Health (Minneapolis, USA) searched the PubMed database for studies of DCIS published in English between January 1970 and July 2010 to examine the relationship between ipsilateral breast tumor recurrence (IBTR) and margin status after BCS for DCIS. More...
Women with DCIS were stratified into two groups - BCS with or without radiotherapy. The researchers then estimates the odds ratios (OR) of IBTR for groups with negative margins and positive margins, as well as examining specific margin thresholds using mixed treatment comparisons and metaregression techniques.

The results showed that in 21 studies, a total of 1,066 IBTR events occurred in 7,564 patients, including BCS alone (565 IBTR events in 3,098 patients) and BCS with radiotherapy (501 IBTR events in 4,466 patients). Negative margins were associated with reduced risk of IBTR in both patients with radiotherapy and in patients without radiotherapy. The researchers concluded that a negative margin of at least 10 mm cut ipsilateral recurrence risk by a significant 54%, compared with getting a negative margin of only greater than 2 mm. The study was published early online on March 22, 2012, in the Journal of the National Cancer Institute.

“Within cosmetic constraint, surgeons should attempt to achieve negative margins as wide as possible in their first attempt,” concluded lead author Shi-Yi Wang, MD, and colleagues. “A negative margin threshold greater than 10 mm is the best option compared with other margin thresholds. Radiotherapy should complement the targeting of wider free margins to minimize ipsilateral breast tumor recurrence.”

DCIS is the most common type of noninvasive breast cancer, in which the abnormal cells are contained inside the milk ducts. If DCIS is not treated, it may eventually develop into invasive breast cancer, which can spread outside the ducts into the breast tissue and then possibly to other parts of the body. Since DCIS cannot usually be felt as a breast lump or other breast change, most cases are diagnosed following routine screening with mammograms or ultrasound, appearing as microcalcifications.

Related Links:

University of Minnesota School of Public Health




Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.